Q3 Earnings Forecast for USPH Issued By William Blair

U.S. Physical Therapy, Inc. (NYSE:USPH) – Analysts at William Blair issued their Q3 2025 earnings per share estimates for U.S. Physical Therapy in a report released on Thursday, February 27th. William Blair analyst J. Haase expects that the company will earn $0.84 per share for the quarter. William Blair has a “Market Perform” rating on the stock. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.67 per share.

Other analysts have also recently issued research reports about the stock. Bank of America raised shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and upped their price target for the company from $100.00 to $115.00 in a research report on Monday, December 16th. JMP Securities started coverage on shares of U.S. Physical Therapy in a research report on Monday, December 16th. They set an “outperform” rating and a $113.00 price target on the stock. Barrington Research cut their price target on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating on the stock in a research report on Friday. Citizens Jmp raised shares of U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. Finally, JPMorgan Chase & Co. increased their price objective on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a research report on Tuesday, December 3rd. One analyst has rated the stock with a sell rating, one has given a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $111.50.

U.S. Physical Therapy Stock Performance

Shares of USPH opened at $79.31 on Monday. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. The stock has a market capitalization of $1.20 billion, a P/E ratio of 84.37, a price-to-earnings-growth ratio of 3.54 and a beta of 1.48. The firm’s fifty day simple moving average is $88.20 and its two-hundred day simple moving average is $87.65. U.S. Physical Therapy has a 12 month low of $76.18 and a 12 month high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 earnings per share for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). The company had revenue of $180.45 million during the quarter, compared to analyst estimates of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%.

Institutional Investors Weigh In On U.S. Physical Therapy

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in U.S. Physical Therapy by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 1,084,197 shares of the company’s stock valued at $96,179,000 after buying an additional 6,393 shares during the last quarter. Copeland Capital Management LLC increased its stake in U.S. Physical Therapy by 9.5% in the 4th quarter. Copeland Capital Management LLC now owns 839,356 shares of the company’s stock valued at $74,459,000 after buying an additional 72,715 shares during the last quarter. State Street Corp increased its stake in U.S. Physical Therapy by 17.5% in the 3rd quarter. State Street Corp now owns 667,868 shares of the company’s stock valued at $56,522,000 after buying an additional 99,244 shares during the last quarter. Southernsun Asset Management LLC increased its stake in U.S. Physical Therapy by 4.5% in the 4th quarter. Southernsun Asset Management LLC now owns 571,809 shares of the company’s stock valued at $50,725,000 after buying an additional 24,698 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in U.S. Physical Therapy by 1.9% in the 4th quarter. Dimensional Fund Advisors LP now owns 426,298 shares of the company’s stock valued at $37,818,000 after buying an additional 7,890 shares during the last quarter.

Insider Transactions at U.S. Physical Therapy

In related news, CFO Carey P. Hendrickson sold 516 shares of the firm’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $96.25, for a total value of $49,665.00. Following the transaction, the chief financial officer now owns 20,469 shares of the company’s stock, valued at approximately $1,970,141.25. This trade represents a 2.46 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be given a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.27%. The ex-dividend date is Friday, March 14th. This is a boost from U.S. Physical Therapy’s previous quarterly dividend of $0.44. U.S. Physical Therapy’s dividend payout ratio is 95.65%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.